Related Experiment Videos
Malignant rhabdoid tumor. A morphological and flow cytometric study
D Schmidt1, I Leuschner, D Harms
1Dept. of Pediatric Pathology, University of Kiel, FRG.
Pathology, Research and Practice
|February 1, 1989
Summary
Malignant rhabdoid tumor (MRT) exhibits diverse histopathology and expresses various antigenic markers, often mimicking epithelioid sarcoma. Despite aggressive treatment, prognosis for malignant rhabdoid tumors remains poor.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Malignant rhabdoid tumor (MRT) is a rare and aggressive neoplasm.
- Its histopathological and immunohistochemical profile can be variable, leading to diagnostic challenges.
Purpose of the Study:
- To comprehensively characterize the clinicopathological, immunohistochemical, and flow cytometric features of malignant rhabdoid tumors.
- To explore the diagnostic overlap between MRT and other entities, such as epithelioid sarcoma.
Main Methods:
- Conventional light microscopy, immunohistochemistry, electron microscopy, and flow cytometry were employed.
- Analysis of 16 cases of malignant rhabdoid tumor across various age groups and locations.
Main Results:
- MRT demonstrated diverse histopathological patterns, including myxoid, pseudoalveolar, and hyalinized areas.
- Immunohistochemistry revealed variable expression of vimentin, cytokeratin, desmin, epithelial membrane antigen (EMA), neuron-specific enolase (NSE), and S-100 protein.
- Electron microscopy showed abundant intermediate filaments, and flow cytometry indicated diploid DNA stem lines in all analyzed cases.
Conclusions:
- Malignant rhabdoid tumor presents with greater histopathological diversity than previously recognized.
- The broad expression of antigenic markers can lead to confusion with epithelioid sarcoma.
- Despite aggressive multimodal treatment, the prognosis for malignant rhabdoid tumors remains unfavorable.